Drug design and development

Molecular imaging has joined electroencephalography (EEG), magnetoencephalography, functional magneticresonance imaging (fMRl),and diffuse optical tomographyinmeasuring neuronal activity. fMRl has a spatial resolution of 1 mm and excellent temporal resolution. Both PET and SPECT have spatial resolution of about 1 cm, but low temporal resolution. 

When neurons are activated, the neurons consume more oxygen from the hemoglobin in red blood cells. The increases in blood flow associated with increased neuronal activity begin after 1-5 seconds, and rise to a peak in 4-5 seconds. 

SPECT uses radiotracers that emit single photons rather than positrons. Their distribution in the brain is measured by a ring of radiation detectors surrounding the patient s head, as is the case in PET imaging. SPECT can measure regional brain blood flow to reflect increased neuronal activity. PET and SPECT can image regional molecular processes, for example, the location and availability of neuroreceptors. 

Specific neuroreceptors are identified by specific radiotracers injected intravenously. PET and SPECT images are often fused with computed tomography (CT) and magnetic 

SPECT uses radionuclides, such as tedmetium-99m, rather than positron-emitters, such as carbon-11 or fluorine-18, as is the case with PET. A widely used SPECT radiopharmaceutical is technetium-99m hexamethylpropylene amine oxime, to measure regional cerebral blood flow after systemic administration of the cerebral vasodilator acetazolamide (aceta-zolamide test) to patients with Alzheimer s disease (AD) or vascular dementia (VD). 

---

P. Krogsgaard-Larsen and H. Bungaard, eds.,M Textbook of Drug Design and Development, Harwood Academic Pubhshers, Swit2edand, 1991. 

The previous sections have described methods to obtain 2-pyridone scaffolds. Both in the construction of new materials and especially in drug design and development, there is a desire to be able to derivatize and optimize the lead structures. In the following sections, some recent developments using MAOS to effectively substitute and derivatize 2-pyridone heterocycles are described. The reaction types described range from electrophilic-, and nucleophilic reactions to transition metal-catalyzed transformations (Fig. 7). To get an overview of how these systems behave, their characteristics imder conventional heating is first described in brevity. 

Erd, P., Mtihlbacher, J. Rohde, B., Selzer, P. Web-based cheminformatics and molecular property prediction tools supporting drug design and development at Novartis. SAR QSAR Environ. Res. 2003, 34, 321-328. 

It is sometimes assumed that every phenol metabolite indicates the formation of an arene oxide intermediate however, as discussed above, arene oxides are not obligate intermediates in the formation of phenols. This is an important distinction because arene oxides and other epoxides are reactive intermediates that can be toxic or even carcinogenic, e.g., epoxides of some polycyclic aromatic hydrocarbons. The question of whether their formation is obligatory is significant for drug design and development and has implications for toxicity as discussed in Chapter 8. 

Grossman, S.J., Overview drug metabolism in the modem pharmaceutical industry. In Drug Metabolism in Drug Design and Development, Zhang, D., Zhu, M. and Humphreys, W.G. (eds). J. Wiley Sons, Inc., 2008, pp. 3-13. 

P. N. Kourounakis E. Rekka, Introduction. In Advanced Drug Design and Development A Medicinal Chemistry Approach, P. N. Kourounakis, E. Rekka, Eds. Ellis Harwood New York, 1994 pp 1-141. 

The special advantages of selective substitution of fluorine in drug design and development are well recognized and have been reviewed extensively [21]. Small size and high electronegativity impart special properties to fluorinated... 

K.L. Kirk, Selective fluorination in drug design and development, an overview of biochemical rationales, Curr. Top. Med. Chem. 6 (2006) 1447-1456. 

Prostaglandins, thromboxane, and the leukotrienes are lipids that are collectively called eicosanoids, since they are all derived from the C20 fatty acid, arachidonic acid [eicosa (Gr.) = twenty]. Over the past twenty years, the eicosanoids have emerged as important molecules around which to target drug design and development. 

F. L. Sorgi and H. Schreier. Non-viral vectors for gene delivery, Biopharmaceutical Drug Design and Development (S. Wu-Pong, and Y. Rojanasakul, eds.), The Hu-mana Press, Totowa, N.J., 1999, pp. 107-142. 

Fig. 1. Overview of the role of NMR in drug design and development. NMR methods are indicated in dark boxes. Screening-based approaches are shaded grey.

Centre for Drug Design and Development, The University of Queensland, Brisbane, QLD 4072, Australia... 

---